Literature DB >> 29128185

Correct extent of thyroidectomy is poorly predicted preoperatively by the guidelines of the American Thyroid Association for low and intermediate risk thyroid cancers.

Mashaal Dhir1, Kelly L McCoy1, N Paul Ohori2, Cameron D Adkisson1, Shane O LeBeau3, Sally E Carty1, Linwah Yip4.   

Abstract

BACKGROUND: Recent guidelines from the American Thyroid Association recommend thyroid lobectomy for intrathyroidal differentiated thyroid cancers <4 cm. Our aim was to examine histology from patients with cytologic results that were positive or suspicious for malignancy to assess the extent of initial thyroidectomy based on criteria from the 2015 American Thyroid Association guidelines.
METHODS: We studied consecutive patients who had either a positive or suspicious for malignancy cytologic diagnosis and under prior American Thyroid Association guidelines underwent initial total thyroidectomy ± lymphadenectomy.
RESULTS: Among 447 patients, high-risk features necessitating total thyroidectomy were present in 19% (72/380) of positive and 15% (10/67) of suspicious for malignancy patients (P = .5). Intermediate-risk features on histology were identified postoperatively in 46% (175/380) with positive and 15% (18/67) with suspicious for malignancy fine-needle aspiration results. In multivariable analysis, preoperative factors associated with intermediate-risk disease included age ≥45 years, women, larger tumor size, positive fine-needle aspiration cytology, and BRAF V600E or RET/PTC positivity.
CONCLUSION: When patients are considered for lobectomy under the 2015 American Thyroid Association guidelines, ~ 60% with positive and 30% with suspicious for malignancy cytology would need completion thyroidectomy based on intermediate-risk disease. The cost and risk implications of the new American Thyroid Association strategy were substantial and better tools are needed to improve preoperative risk stratification.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29128185     DOI: 10.1016/j.surg.2017.04.029

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  12 in total

1.  Need for Completion Thyroidectomy in Patients Undergoing Lobectomy for Indeterminate and High-Risk Nodules: Impact of Intra-Operative Findings and Final Pathology.

Authors:  Edwina C Moore; Samuel Zolin; Vikram Krishnamurthy; Judy Jin; Joyce Shin; Eren Berber; Allan Siperstein
Journal:  World J Surg       Date:  2020-02       Impact factor: 3.352

2.  Does the ATA Risk Stratification Apply to Patients with Papillary Thyroid Microcarcinoma?

Authors:  Dessislava I Stefanova; Arpita Bose; Timothy M Ullmann; Jessica N Limberg; Brendan M Finnerty; Rasa Zarnegar; Thomas J Fahey; Toni Beninato
Journal:  World J Surg       Date:  2020-02       Impact factor: 3.352

Review 3.  Total thyroidectomy versus thyroid lobectomy in the treatment of papillary carcinoma.

Authors:  Marco Raffaelli; Serena Elisa Tempera; Luca Sessa; Celestino Pio Lombardi; Carmela De Crea; Rocco Bellantone
Journal:  Gland Surg       Date:  2020-01

Review 4.  Testing for BRAF (V600E) Mutation in Thyroid Nodules with Fine-Needle Aspiration (FNA) Read as Suspicious for Malignancy (Bethesda V, Thy4, TIR4): a Systematic Review and Meta-analysis.

Authors:  Pierpaolo Trimboli; Lorenzo Scappaticcio; Giorgio Treglia; Leo Guidobaldi; Massimo Bongiovanni; Luca Giovanella
Journal:  Endocr Pathol       Date:  2020-03       Impact factor: 3.943

5.  Modulating the extension of thyroidectomy in patients with papillary thyroid carcinoma pre-operatively eligible for lobectomy: reliability of ipsilateral central neck dissection.

Authors:  M Raffaelli; C De Crea; L Sessa; S E Tempera; G Fadda; A Pontecorvi; R Bellantone
Journal:  Endocrine       Date:  2020-08-20       Impact factor: 3.633

6.  Understanding surgical decision-making in older adults with differentiated thyroid cancer: A discrete choice experiment.

Authors:  Whitney Sutton; Becky Genberg; Jason D Prescott; Dorry L Segev; Martha A Zeiger; Karen Bandeen-Roche; Aarti Mathur
Journal:  Surgery       Date:  2020-05-28       Impact factor: 3.982

7.  The Identification of Intraoperative Risk Factors Can Reduce, but Not Exclude, the Need for Completion Thyroidectomy in Low-Risk Papillary Thyroid Cancer Patients.

Authors:  Steven J Craig; Andrew M Bysice; Steven C Nakoneshny; Janice L Pasieka; Shamir P Chandarana
Journal:  Thyroid       Date:  2020-01-09       Impact factor: 6.568

8.  Follicular proliferation TIR3B: the role of total thyroidectomy vs lobectomy.

Authors:  Andrea Polistena; Alessandro Sanguinetti; Roberta Lucchini; Stefano Avenia; Sergio Galasse; Raffaele Farabi; Massimo Monacelli; Nicola Avenia
Journal:  BMC Surg       Date:  2019-04-24       Impact factor: 2.102

Review 9.  Liquid Biopsy in Thyroid Cancer: New Insight.

Authors:  Fatemeh Khatami; Seyed Mohammad Tavangar
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2018-07-01

Review 10.  Thyroid Lobectomy for Low to Intermediate Risk Differentiated Thyroid Cancer.

Authors:  Dana M Hartl; Joanne Guerlain; Ingrid Breuskin; Julien Hadoux; Eric Baudin; Abir Al Ghuzlan; Marie Terroir-Cassou-Mounat; Livia Lamartina; Sophie Leboulleux
Journal:  Cancers (Basel)       Date:  2020-11-06       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.